CaltechAUTHORS
  A Caltech Library Service

Lipopolysaccharide Is a Potent Monocyte/Macrophage-specific Stimulator of Human Immunodeficiency Virus Type 1 Expression

Pomerantz, Roger J. and Feinberg, Mark B. and Trono, Didier and Baltimore, David (1990) Lipopolysaccharide Is a Potent Monocyte/Macrophage-specific Stimulator of Human Immunodeficiency Virus Type 1 Expression. Journal of Experimental Medicine, 172 (1). pp. 253-261. ISSN 0022-1007. http://resolver.caltech.edu/CaltechAUTHORS:20120509-133826978

[img]
Preview
PDF - Published Version
Creative Commons Attribution Non-commercial Share Alike.

1331Kb

Use this Persistent URL to link to this item: http://resolver.caltech.edu/CaltechAUTHORS:20120509-133826978

Abstract

Lipopolysaccharide (LPS) potently stimulates human immunodeficiency virus type 1-long terminal repeat (HIV-1-LTR) CAT constructs transfected into monocyte/macrophage-like cell lines but not a T cell line. This effect appears to be mediated through the induction of nuclear factor kappa B (NF-kappa B). Electrophoretic mobility shift assays demonstrate that LPS induces a DNA binding activity indistinguishable from NF-kappa B in U937 and THP-1 cells. LPS is also shown to dramatically increase HIV-1 production from a chronically infected monocyte/macrophage-like cloned cell line, U1, which produces very low levels of HIV-1 at baseline. The stimulation of viral production from this cell line occurs only if these cells are treated with granulocyte/macrophage colony-stimulating factor (GM-CSF) before treatment with LPS. This stimulation of HIV-1 production is correlated with an increase in the level of HIV-1 RNA and and activation of NF-kappa B. LPS is not able to induce HIV-1 production in a cloned T cell line. The effect of LPS on HIV-1 replication occurs at picogram per milliliter concentrations and may be clinically significant in understanding the variability of the natural history of HIV-1 infection.


Item Type:Article
Related URLs:
URLURL TypeDescription
http://dx.doi.org/10.1084/jem.172.1.253 DOIUNSPECIFIED
http://jem.rupress.org/content/172/1/253.abstractPublisherUNSPECIFIED
Additional Information:© 1990 Rockefeller University Press. Received for publication 23 February 1990. Published July 1, 1990. We thank Drs . Sankar Ghosh, Mark Muesing, Anthony De Franco, and Towia Libermann for critical discussions. We thank Dr. Michael Lenardo for providing some oligonucleotides and Dr. Jacqueline Pierce for providing some of the plasmids used in these studies. We also thank Patricia Waddy for excellent secretarial assistance. R. J. Pomerantz is funded under Physician Scientist Award AI-00930. This work was supported in part by U.S. Public Health Service grants AI-26463 and HIA3510.
Funders:
Funding AgencyGrant Number
Physician Scientist AwardAI-00930
U. S. Public Health Service (USPHS)AI-26463
U. S. Public Health Service (USPHS)HL-43510
Record Number:CaltechAUTHORS:20120509-133826978
Persistent URL:http://resolver.caltech.edu/CaltechAUTHORS:20120509-133826978
Official Citation:Lipopolysaccharide is a potent monocyte/macrophage-specific stimulator of human immunodeficiency virus type 1 expression. R J Pomerantz, M B Feinberg, D Trono, and D Baltimore 172:253-261. doi:10.1084/jem.172.1.253
Usage Policy:No commercial reproduction, distribution, display or performance rights in this work are provided.
ID Code:31387
Collection:CaltechAUTHORS
Deposited By: Ruth Sustaita
Deposited On:09 May 2012 21:31
Last Modified:26 Dec 2012 15:11

Repository Staff Only: item control page